Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Jun;142(6):787–796.

Paraneoplastic Syndromes of the Nervous System

George Palma 1
PMCID: PMC1306181  PMID: 2992171

Abstract

The paraneoplastic disorders of the nervous system are clinicopathologic syndromes that occur in association with systemic cancer. Dysfunction of any part of the nervous system or its effector organs may be produced by a paraneoplastic process. The temporal relationship between the onset of a paraneoplastic syndrome and the diagnosis of the associate cancer varies. Most of the paraneoplastic syndromes of the nervous system may appear months to years before the cancer is discovered. The pathogenesis of most of the paraneoplastic syndromes of the nervous system is unknown and specific, effective therapy is lacking. With rare exceptions, treatment of the associated cancer seldom alters the course of patients with these syndromes. However, in other paraneoplastic syndromes such as myasthenia gravis, myasthenic syndrome of Eaton-Lambert and polymyositis-dermatomyositis an autoimmune pathogenesis is established or strongly suspected.

Full text

PDF
787

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed M. N., Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J. 1975 Sep 6;113(5):410–412. [PMC free article] [PubMed] [Google Scholar]
  2. Altman A. J., Baehner R. L. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer. 1976 Feb;37(2):846–852. doi: 10.1002/1097-0142(197602)37:2<846::aid-cncr2820370233>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  3. Barnes B. D., Brant-Zawadzki M., Mentzer W. Digital subtraction angiography in the diagnosis of superior sagittal sinus thrombosis. Neurology. 1983 Apr;33(4):508–510. doi: 10.1212/wnl.33.4.508. [DOI] [PubMed] [Google Scholar]
  4. Barnes B. E., Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med. 1976 Jan;84(1):68–76. doi: 10.7326/0003-4819-84-1-68. [DOI] [PubMed] [Google Scholar]
  5. Barron K. D., Rodichok L. D. Cancer and disorders of motor neurons. Adv Neurol. 1982;36:267–272. [PubMed] [Google Scholar]
  6. Behan P. O., Shakir R. A., Simpson J. A., Burnett A. K., Allan T. L., Haase G. Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet. 1979 Sep 1;2(8140):438–440. doi: 10.1016/s0140-6736(79)91492-2. [DOI] [PubMed] [Google Scholar]
  7. Behan W. M., Behan P. O. Disturbance of regulatory lymphocyte subsets in polymyositis. Ann Neurol. 1984 Jan;15(1):112–114. doi: 10.1002/ana.410150126. [DOI] [PubMed] [Google Scholar]
  8. Biller J., Challa V. R., Toole J. F., Howard V. J. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982 Feb;39(2):95–98. doi: 10.1001/archneur.1982.00510140029007. [DOI] [PubMed] [Google Scholar]
  9. Bohan A., Peter J. B., Bowman R. L., Pearson C. M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977 Jul;56(4):255–286. doi: 10.1097/00005792-197707000-00001. [DOI] [PubMed] [Google Scholar]
  10. Brain L., Wilkinson M. Subacute cerebellar degeneration associated with neoplasms. Brain. 1965 Sep;88(3):465–478. doi: 10.1093/brain/88.3.465. [DOI] [PubMed] [Google Scholar]
  11. Brandt S., Carlsen N., Glenting P., Helweg-Larsen J. Encephalopathia myoclonica infantilis (Kinsbourne) and neuroblastoma in children. A report of three cases. Dev Med Child Neurol. 1974 Jun;16(3):286–294. doi: 10.1111/j.1469-8749.1974.tb03339.x. [DOI] [PubMed] [Google Scholar]
  12. Bray P. F., Ziter F. A., Lahey M. E., Myers G. G. The coincidence of neuroblastoma and acute cerebellar encephalopathy. J Pediatr. 1969 Dec;75(6):983–990. doi: 10.1016/s0022-3476(69)80335-5. [DOI] [PubMed] [Google Scholar]
  13. Brazis P. W., Biller J., Fine M., Palacios E., Pagano R. J. Cerebellar degeneration with Hodgkin's disease: computed tomographic correlation and literature review. Arch Neurol. 1981 Apr;38(4):253–256. doi: 10.1001/archneur.1981.00510040079015. [DOI] [PubMed] [Google Scholar]
  14. Brennan L. V., Craddock P. R. Limbic encephalopathy as a nonmetastatic complication of oat cell lung cancer. Its reversal after treatment of the primary lung lesion. Am J Med. 1983 Sep;75(3):518–520. doi: 10.1016/0002-9343(83)90358-3. [DOI] [PubMed] [Google Scholar]
  15. Buckingham J. M., Howard F. M., Jr, Bernatz P. E., Payne W. S., Harrison E. G., Jr, O'Brien P. C., Weiland L. H. The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg. 1976 Oct;184(4):453–458. doi: 10.1097/00000658-197610000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bunch T. W. Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum. 1981 Jan;24(1):45–48. doi: 10.1002/art.1780240107. [DOI] [PubMed] [Google Scholar]
  17. Buonanno F. S., Moody D. M., Ball M. R., Laster D. W. Computed cranial tomographic findings in cerebral sinovenous occlusion. J Comput Assist Tomogr. 1978 Jul;2(3):281–290. doi: 10.1097/00004728-197807000-00008. [DOI] [PubMed] [Google Scholar]
  18. Callen J. P., Hyla J. F., Bole G. G., Jr, Kay D. R. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol. 1980 Mar;116(3):295–298. [PubMed] [Google Scholar]
  19. Calman K. C. Malignancy. Cancer cachexia. Br J Hosp Med. 1982 Jan;27(1):28-9, 33-4. [PubMed] [Google Scholar]
  20. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):496–505. doi: 10.1111/j.1749-6632.1966.tb45497.x. [DOI] [PubMed] [Google Scholar]
  21. Collins R. C., Al-Mondhiry H., Chernik N. L., Posner J. B. Neurologic manifestations of intravascular coagulation in patients with cancer. A clinicopathologic analysis of 12 cases. Neurology. 1975 Sep;25(9):795–806. doi: 10.1212/wnl.25.9.795. [DOI] [PubMed] [Google Scholar]
  22. Coombes R. C. Malignancy. Metabolic manifestations of cancer. Br J Hosp Med. 1982 Jan;27(1):21-4, 26-7. [PubMed] [Google Scholar]
  23. Corsellis J. A., Goldberg G. J., Norton A. R. "Limbic encephalitis" and its association with carcinoma. Brain. 1968 Sep;91(3):481–496. doi: 10.1093/brain/91.3.481. [DOI] [PubMed] [Google Scholar]
  24. Croft P. B., Henson R. A., Urich H., Wilkinson P. C. Sensory neuropathy with bronchial carcinoma: a study of four cases showing serological abnormalities. Brain. 1965 Sep;88(3):501–514. doi: 10.1093/brain/88.3.501. [DOI] [PubMed] [Google Scholar]
  25. Croft P. B., Urich H., Wilkinson M. Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain. 1967 Mar;90(1):31–66. doi: 10.1093/brain/90.1.31. [DOI] [PubMed] [Google Scholar]
  26. Cull-Candy S. G., Miledi R., Trautmann A., Uchitel O. D. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J Physiol. 1980 Feb;299:621–638. doi: 10.1113/jphysiol.1980.sp013145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dau P. C., Denys E. H. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Ann Neurol. 1982 Jun;11(6):570–575. doi: 10.1002/ana.410110604. [DOI] [PubMed] [Google Scholar]
  28. Dau P. C., Lindstrom J. M., Cassel C. K., Denys E. H., Shev E. E., Spitler L. E. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med. 1977 Nov 24;297(21):1134–1140. doi: 10.1056/NEJM197711242972102. [DOI] [PubMed] [Google Scholar]
  29. Dau P. C. Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol. 1981 Sep;38(9):544–552. doi: 10.1001/archneur.1981.00510090038003. [DOI] [PubMed] [Google Scholar]
  30. Dorfman L. J., Forno L. S. Paraneoplastic encephalomyelitis. Acta Neurol Scand. 1972;48(5):556–574. doi: 10.1111/j.1600-0404.1972.tb07576.x. [DOI] [PubMed] [Google Scholar]
  31. Drachman D. B., Adams R. N., Josifek L. F., Self S. G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med. 1982 Sep 23;307(13):769–775. doi: 10.1056/NEJM198209233071301. [DOI] [PubMed] [Google Scholar]
  32. Drachman D. B. Myasthenia gravis (first of two parts). N Engl J Med. 1978 Jan 19;298(3):136–142. doi: 10.1056/NEJM197801192980305. [DOI] [PubMed] [Google Scholar]
  33. Dyken P., Kolár O. Dancing eyes, dancing feet: infantile polymyoclonia. Brain. 1968 Jun;91(2):305–320. doi: 10.1093/brain/91.2.305. [DOI] [PubMed] [Google Scholar]
  34. EATON L. M., LAMBERT E. H. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc. 1957 Mar 30;163(13):1117–1124. doi: 10.1001/jama.1957.02970480021005. [DOI] [PubMed] [Google Scholar]
  35. Ellenberger C., Jr, Campa J. F., Netsky M. G. Opsoclonus and parenchymatous degeneration of the cerebellum. The cerebellar origin of an abnormal ocular movement. Neurology. 1968 Nov;18(11):1041–1046. doi: 10.1212/wnl.18.11.1041. [DOI] [PubMed] [Google Scholar]
  36. Elmqvist D., Lambert E. H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc. 1968 Oct;43(10):689–713. [PubMed] [Google Scholar]
  37. Engel A. G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984 Aug;16(2):209–215. doi: 10.1002/ana.410160207. [DOI] [PubMed] [Google Scholar]
  38. Estevez C. M., Corya B. C. Serial echocardiographic abnormalities in nonbacterial thrombotic endocarditis of the mitral valve. Chest. 1976 Jun;69(6):801–804. doi: 10.1378/chest.69.6.801. [DOI] [PubMed] [Google Scholar]
  39. Fawcett D. P., McBrien M. P. Transitional cell carcinoma of the renal pelvis presenting with peripheral neuropathy. Br J Urol. 1977 Jun;49(3):202–202. doi: 10.1111/j.1464-410x.1977.tb04103.x. [DOI] [PubMed] [Google Scholar]
  40. Fujii Y., Monden Y., Nakahara K., Hashimoto J., Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology. 1984 Sep;34(9):1182–1186. doi: 10.1212/wnl.34.9.1182. [DOI] [PubMed] [Google Scholar]
  41. Fukuhara N., Takamori M., Gutmann L., Chou S. M. Eaton-Lambert syndrome. Ultrastructural study of the motor end-plates. Arch Neurol. 1972 Jul;27(1):67–78. doi: 10.1001/archneur.1972.00490130069009. [DOI] [PubMed] [Google Scholar]
  42. Genkins G., Papatestas A. E., Horowitz S. H., Kornfield P. Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med. 1975 Apr;58(4):517–524. doi: 10.1016/0002-9343(75)90125-4. [DOI] [PubMed] [Google Scholar]
  43. Greenlee J. E., Brashear H. R. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983 Dec;14(6):609–613. doi: 10.1002/ana.410140603. [DOI] [PubMed] [Google Scholar]
  44. Halperin J. J., Richardson E. P., Jr, Ellis J., Ross J. S., Wray S. H. Paraneoplastic encephalomyelitis and neuropathy. Report of a case. Arch Neurol. 1981 Dec;38(12):773–775. doi: 10.1001/archneur.1981.00510120073012. [DOI] [PubMed] [Google Scholar]
  45. Handforth A., Nag S., Sharp D., Robertson D. M. Paraneoplastic subacute necrotic myelopathy. Can J Neurol Sci. 1983 Aug;10(3):204–207. doi: 10.1017/s0317167100044942. [DOI] [PubMed] [Google Scholar]
  46. Henriksson K. G., Sandstedt P. Polymyositis--treatment and prognosis. A study of 107 patients. Acta Neurol Scand. 1982 Apr;65(4):280–300. doi: 10.1111/j.1600-0404.1982.tb03087.x. [DOI] [PubMed] [Google Scholar]
  47. Henson R. A., Hoffman H. L., Urich H. Encephalomyelitis with carcinoma. Brain. 1965 Sep;88(3):449–464. doi: 10.1093/brain/88.3.449. [DOI] [PubMed] [Google Scholar]
  48. Hickey W. F., Garnick M. B., Henderson I. C., Dawson D. M. Primary cerebral venous thrombosis in patients with cancer--a rarely diagnosed paraneoplastic syndrome. Report of three cases and review of the literature. Am J Med. 1982 Nov;73(5):740–750. doi: 10.1016/0002-9343(82)90418-1. [DOI] [PubMed] [Google Scholar]
  49. Horwich M. S., Cho L., Porro R. S., Posner J. B. Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol. 1977 Jul;2(1):7–19. doi: 10.1002/ana.410020103. [DOI] [PubMed] [Google Scholar]
  50. Hubbard W. N., Walport M. J., Halnan K. E., Beaney R. P., Hughes G. R. Remission from polymyositis after total body irradiation. Br Med J (Clin Res Ed) 1982 Jun 26;284(6333):1915–1916. doi: 10.1136/bmj.284.6333.1915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ishikawa K., Engelhardt J. K., Fujisawa T., Okamoto T., Katsuki H. A neuromuscular transmission block produced by a cancer tissue extract derived from a patient with the myasthenic syndrome. Neurology. 1977 Feb;27(2):140–143. doi: 10.1212/wnl.27.2.141. [DOI] [PubMed] [Google Scholar]
  52. Julien J., Vital C., Vallat J. M., Lagueny A., Deminiere C., Darriet D. Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol. 1978 Jul;35(7):423–425. doi: 10.1001/archneur.1978.00500310025005. [DOI] [PubMed] [Google Scholar]
  53. KLINGON G. H. THE GUILLAIN-BARR'E SYNDROME ASSOCIATED WITH CANCER. Cancer. 1965 Feb;18:157–163. doi: 10.1002/1097-0142(196502)18:2<157::aid-cncr2820180206>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  54. Keesey J., Bein M., Mink J., Sample F., Sarti D., Mulder D., Herrmann C., Jr, Peter J. B. Detection of thymoma in myasthenia gravis. Neurology. 1980 Mar;30(3):233–239. doi: 10.1212/wnl.30.3.233. [DOI] [PubMed] [Google Scholar]
  55. Kelly J. J., Jr, Kyle R. A., Miles J. M., Dyck P. J. Osteosclerotic myeloma and peripheral neuropathy. Neurology. 1983 Feb;33(2):202–210. doi: 10.1212/wnl.33.2.202. [DOI] [PubMed] [Google Scholar]
  56. Kelly J. J., Jr, Kyle R. A., Miles J. M., O'Brien P. C., Dyck P. J. The spectrum of peripheral neuropathy in myeloma. Neurology. 1981 Jan;31(1):24–31. doi: 10.1212/wnl.31.1.24. [DOI] [PubMed] [Google Scholar]
  57. Kempin S. Disorders of hemostasis in malignancy. Curr Probl Cancer. 1979 Oct;4(4):21–26. doi: 10.1016/s0147-0272(79)80012-4. [DOI] [PubMed] [Google Scholar]
  58. Kooiker J. C., MacLean J. M., Sumi S. M. Cerebral embolism, marantic endocarditis, and cancer. Arch Neurol. 1976 Apr;33(4):260–264. doi: 10.1001/archneur.1976.00500040044006. [DOI] [PubMed] [Google Scholar]
  59. Kornfeld P., Ambinder E. P., Papatestas A. E., Bender A. N., Genkins G. Plasmapheresis in myasthenia gravis: controlled study. Lancet. 1979 Sep 22;2(8143):629–629. doi: 10.1016/s0140-6736(79)91680-5. [DOI] [PubMed] [Google Scholar]
  60. Lang B., Newsom-Davis J., Wray D., Vincent A., Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet. 1981 Aug 1;2(8240):224–226. doi: 10.1016/s0140-6736(81)90474-8. [DOI] [PubMed] [Google Scholar]
  61. Lindstrom J. M., Lambert E. H. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology. 1978 Feb;28(2):130–138. doi: 10.1212/wnl.28.2.130. [DOI] [PubMed] [Google Scholar]
  62. Lisak R. P., Mitchell M., Zweiman B., Orrechio E., Asbury A. K. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol. 1977 Jan;1(1):72–78. doi: 10.1002/ana.410010107. [DOI] [PubMed] [Google Scholar]
  63. MACDONALD R. A., ROBBINS S. L. The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases. Ann Intern Med. 1957 Feb;46(2):255–273. doi: 10.7326/0003-4819-46-2-255. [DOI] [PubMed] [Google Scholar]
  64. MANCALL E. L., ROSALES R. K. NECROTIZING MYELOPATHY ASSOCIATED WITH VISCERAL CARCINOMA. Brain. 1964 Dec;87:639–656. doi: 10.1093/brain/87.4.639. [DOI] [PubMed] [Google Scholar]
  65. Mittag T., Kornfeld P., Tormay A., Woo C. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med. 1976 Mar 25;294(13):691–694. doi: 10.1056/NEJM197603252941303. [DOI] [PubMed] [Google Scholar]
  66. Moe P. G., Nellhaus G. Infantile polymyoclonia-opsoclonus syndrome and neural crest tumors. Neurology. 1970 Aug;20(8):756–764. doi: 10.1212/wnl.20.8.756. [DOI] [PubMed] [Google Scholar]
  67. Molenaar P. C., Newsom-Davis J., Polak R. L., Vincent A. Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle. Neurology. 1982 Sep;32(9):1061–1065. doi: 10.1212/wnl.32.9.1061. [DOI] [PubMed] [Google Scholar]
  68. Namba T., Brunner N. G., Grob D. Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine (Baltimore) 1978 Sep;57(5):411–433. doi: 10.1097/00005792-197809000-00002. [DOI] [PubMed] [Google Scholar]
  69. Nausieda P. A., Tanner C. M., Weiner W. J. Opsoclonic cerebellopathy: A paraneoplastic syndrome responsive to thiamine. Arch Neurol. 1981 Dec;38(12):780–781. doi: 10.1001/archneur.1981.00510120080015. [DOI] [PubMed] [Google Scholar]
  70. Ojeda V. J. The classification of spinal cord disorders in patients with cancer. Pathology. 1983 Apr;15(2):122–124. doi: 10.3109/00313028309084694. [DOI] [PubMed] [Google Scholar]
  71. Ongerboer de Visser B. W., Feltkamp-Vroom T. M., Feltkamp C. A. Sural nerve immune deposits in polyneuropathy as a remote effect of malignancy. Ann Neurol. 1983 Sep;14(3):261–266. doi: 10.1002/ana.410140303. [DOI] [PubMed] [Google Scholar]
  72. Paone J. F., Jeyasingham K. Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Engl J Med. 1980 Jan 17;302(3):156–156. doi: 10.1056/NEJM198001173020305. [DOI] [PubMed] [Google Scholar]
  73. Posner J. B. Neurologic complications of systemic cancer. Dis Mon. 1978 Nov;25(2):1–60. doi: 10.1016/s0011-5029(78)80010-8. [DOI] [PubMed] [Google Scholar]
  74. ROOKE E. D., EATON L. M., LAMBERT E. H., HODGSON C. H. Myasthenia and malignant intrathoracic tumor. Med Clin North Am. 1960 Jul;44:977–988. doi: 10.1016/s0025-7125(16)33984-0. [DOI] [PubMed] [Google Scholar]
  75. Read D., Warlow C. Peripheral neuropathy and solitary plasmacytoma. J Neurol Neurosurg Psychiatry. 1978 Feb;41(2):177–184. doi: 10.1136/jnnp.41.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Reddy R. V., Vakili S. T. Midbrain encephalitis as a remote effect of a malignant neoplasm. Arch Neurol. 1981 Dec;38(12):781–782. doi: 10.1001/archneur.1981.00510120081016. [DOI] [PubMed] [Google Scholar]
  77. Renkawek K., Kida E. Combined acute necrotic myelopathy (ANM) and cerebellar degeneration associated with malignant disease. Clin Neuropathol. 1983;2(2):90–94. [PubMed] [Google Scholar]
  78. Richman D. P., Patrick J., Arnason B. G. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med. 1976 Mar 25;294(13):694–698. doi: 10.1056/NEJM197603252941304. [DOI] [PubMed] [Google Scholar]
  79. Ross A. T., Zeman W. Opsoclonus, occult carcinoma, and chemical pathology in dentate nuclei. Arch Neurol. 1967 Nov;17(5):546–551. doi: 10.1001/archneur.1967.00470290100013. [DOI] [PubMed] [Google Scholar]
  80. Rubenstein A. E., Horowitz S. H., Bender A. N. Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology. 1979 May;29(5):720–723. doi: 10.1212/wnl.29.5.720. [DOI] [PubMed] [Google Scholar]
  81. SILVERSTEIN A., DONIGER D. E. NEUROLOGIC COMPLICATIONS OF MYELOMATOSIS. Arch Neurol. 1963 Nov;9:534–544. doi: 10.1001/archneur.1963.00460110102011. [DOI] [PubMed] [Google Scholar]
  82. Schmid A. H., Riede U. N. A morphometric study of the cerebellar cortex from patients with carcinoma. A contribution on quantitative aspects in carcinotoxic cerebellar atrophy. Acta Neuropathol. 1974;28(4):343–352. doi: 10.1007/BF00685288. [DOI] [PubMed] [Google Scholar]
  83. Schold S. C., Cho E. S., Somasundaram M., Posner J. B. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol. 1979 Mar;5(3):271–287. doi: 10.1002/ana.410050310. [DOI] [PubMed] [Google Scholar]
  84. Schuffler M. D., Baird H. W., Fleming C. R., Bell C. E., Bouldin T. W., Malagelada J. R., McGill D. B., LeBauer S. M., Abrams M., Love J. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med. 1983 Feb;98(2):129–134. doi: 10.7326/0003-4819-98-2-129. [DOI] [PubMed] [Google Scholar]
  85. Schwartzman R. J., Hill J. B. Neurologic complications of disseminated intravascular coagulation. Neurology. 1982 Aug;32(8):791–797. doi: 10.1212/wnl.32.8.791. [DOI] [PubMed] [Google Scholar]
  86. Senelick R. C., Bray P. F., Lahey M. E., VanDyk H. J., Johnson D. G. Neuroblastoma and myoclonic encephalopathy: two cases and a review of the literature. J Pediatr Surg. 1973 Oct;8(5):623–632. doi: 10.1016/0022-3468(73)90400-4. [DOI] [PubMed] [Google Scholar]
  87. Siegel R. J., Ginzton L. E., Flanagan K., Criley J. M. Marantic endocarditis: diagnosis by 2-D echocardiography. Chest. 1981 Jul;80(1):118–119. doi: 10.1378/chest.80.1.118-b. [DOI] [PubMed] [Google Scholar]
  88. Sigsbee B., Deck M. D., Posner J. B. Nonmetastatic superior sagittal sinus thrombosis complicating systemic cancer. Neurology. 1979 Feb;29(2):139–146. doi: 10.1212/wnl.29.2.139. [DOI] [PubMed] [Google Scholar]
  89. Sipilä R., Leinonen H., Juntunen J. Paraneoplastic polyneuropathy associated with a carcinoid tumor of the cecum. Acta Med Scand. 1982;212(3):183–184. doi: 10.1111/j.0954-6820.1982.tb03195.x. [DOI] [PubMed] [Google Scholar]
  90. Slater G., Papatestas A. E., Genkins G., Kornfeld P., Horowitz S. H., Bender A. Thymomas in patients with myasthenia gravis. Ann Surg. 1978 Aug;188(2):171–174. doi: 10.1097/00000658-197808000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Somasundaram M., Cho E. S., Posner J. B. Anterior horn cell degeneration as a "remote effect" of lymphoma. Trans Am Neurol Assoc. 1975;100:144–148. [PubMed] [Google Scholar]
  92. Steven M. M., Mackay I. R., Carnegie P. R., Bhathal P. S., Anderson R. M. Cerebellar cortical degeneration with ovarian carcinoma. Postgrad Med J. 1982 Jan;58(675):47–51. doi: 10.1136/pgmj.58.675.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Streib E. W., Rothner A. D. Eaton-Lambert myasthenic syndrome: long-term treatment of three patients with prednisone. Ann Neurol. 1981 Nov;10(5):448–453. doi: 10.1002/ana.410100507. [DOI] [PubMed] [Google Scholar]
  94. Swash M., Fox K. P., Davidson A. R. Carcinoid myopathy. Serotonin-induced muscle weakness in man? Arch Neurol. 1975 Aug;32(8):572–574. doi: 10.1001/archneur.1975.00490500092014. [DOI] [PubMed] [Google Scholar]
  95. Trotter J. L., Hendin B. A., Osterland C. K. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol. 1976 Sep;33(9):660–661. doi: 10.1001/archneur.1976.00500090066014. [DOI] [PubMed] [Google Scholar]
  96. Waerness E. Neuromyotonia and bronchial carcinoma. Electromyogr Clin Neurophysiol. 1974 Oct-Dec;14(5-6):527–535. [PubMed] [Google Scholar]
  97. Walsh J. C. Neuromyotonia: an unusual presentation of intrathoracic malignancy. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1086–1091. doi: 10.1136/jnnp.39.11.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Walsh J. C. Neuropathy associated with lymphoma. J Neurol Neurosurg Psychiatry. 1971 Feb;34(1):42–50. doi: 10.1136/jnnp.34.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Walton J. N., Tomlinson B. E., Pearce G. W. Subacute "poliomyelitis" and Hodgkin's disease. J Neurol Sci. 1968 May-Jun;6(3):435–445. doi: 10.1016/0022-510x(68)90029-4. [DOI] [PubMed] [Google Scholar]
  100. Whitaker J. N. Inflammatory myopathy: a review of etiologic and pathogenetic factors. Muscle Nerve. 1982 Oct;5(8):573–592. doi: 10.1002/mus.880050802. [DOI] [PubMed] [Google Scholar]
  101. Zangemeister W. H., Schwendemann G., Colmant H. J. Carcinomatous encephalomyelopathy in conjunction with encephalomyeloradiculitis. J Neurol. 1978 Apr 14;218(1):63–71. doi: 10.1007/BF00314720. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES